These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 163432)

  • 1. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
    Magrath I; Henle W; Owor R; Olweny C
    N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
    Magrath IT; Henle W
    IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 5. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.
    Judson SC; Henle W; Henle G
    N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)].
    Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M
    Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Epstein-Barr virus and American Burkitt's lymphoma.
    Easton JM; Ablashi DV; Levine PH; Armstrong GR
    IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
    [No Abstract]   [Full Text] [Related]  

  • 9. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
    Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
    Sutherland JC; Olweny CL; Levine PH; Mardiney MR
    J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Hodgkin's disease.
    Desforges JF; Rutherford CJ
    Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
    Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
    Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M; Gunven P
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.